Holocene Advisors’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.3M Buy
1,518,686
+236,605
+18% +$10.9M 0.21% 121
2025
Q4
$57.5M Sell
1,282,081
-694,472
-35% -$29.2M 0.12% 193
2025
Q3
$79.4M Buy
1,976,553
+167,078
+9% +$5.88M 0.18% 135
2025
Q2
$56.6M Buy
+1,809,475
New +$59M 0.14% 156
2023
Q4
Sell
-178,470
Closed -$6.1M 857
2023
Q3
$6.1M Sell
178,470
-534,008
-75% -$20M 0.03% 359
2023
Q2
$27.4M Sell
712,478
-273,717
-28% -$10.9M 0.12% 186
2023
Q1
$35.3M Sell
986,195
-205,443
-17% -$7.59M 0.18% 161
2022
Q4
$47M Sell
1,191,638
-637,514
-35% -$23.2M 0.29% 108
2022
Q3
$66M Hold
1,829,152
0.42% 82
2022
Q2
$55.6M Buy
1,829,152
+919,524
+101% +$27.8M 0.34% 103
2022
Q1
$27.8M Buy
+909,628
New +$27.2M 0.15% 164

Other funds holding XENE